FDA Warns Tofacitinib (XELJANZ, XELJANZ XR) Increases Risk of Serious Heart-Related Adverse Effects and Cancer

Worst Pills, Best Pills

An expert, independent second opinion on more than 1,800 prescription drugs, over-the-counter medications, and supplements

Print Friendly

All E-Alerts

E-Alerts

Heart Rhythm Treatment Causes Liver Injury (April 21, 2011)
Kidney Damage Due to Osteoporosis Treatment (March 11, 2011)
Diabetes Treatment and Bladder Cancer (February 21, 2011)
Delayed Ban of Painkiller Propoxyphene (Darvon, Darvocet) Has Cost More Than 1,000 U.S. Lives (November 19, 2010)
FDA Warning: Osteoporosis Drugs and Fractures (November 5, 2010)
Years Later, FDA Corrects Mistake and Bans Meridia (October 8, 2010)
With Avandia, FDA Jeopardizes Diabetics' Health (September 28, 2010)
Lamotrigine (LAMICTAL) and Meningitis (August 17, 2010)
Swine Flu: Important Advice from WorstPills.org (April 30, 2009)
FDA Advisory Committee: "Darvon should be banned!" -- E-alert from WorstPills.org (February 9, 2009)

7 of 10

The information on this website is not intended to substitute for professional medical advice, diagnosis, or treatment. Consult your doctor before changing or discontinuing any medication.

All E-Alerts

Site Links

Subscriptions

Disclaimer